Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
13.43
+0.66 (5.17%)
Jul 5, 2022 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015
Cash & Equivalents
148.994.4638.5662.6520.291.630.02
Short-Term Investments
000000.050
Cash & Cash Equivalents
148.994.4638.5662.6520.291.680.02
Cash Growth
3244.31%-88.45%-38.45%208.87%1106.97%8970.40%-
Receivables
014.1500000
Other Current Assets
2.280.081.011.330.610.540
Total Current Assets
151.2718.6939.5763.9820.92.230.02
Property, Plant & Equipment
0.610.140.330.10.110.150
Goodwill and Intangibles
3.81000000
Other Long-Term Assets
2.2100.040.040.020.02-
Total Long-Term Assets
6.640.140.370.140.130.170
Total Assets
157.9118.8339.9464.1221.032.40.02
Accounts Payable
12.216.713.235.463.592.470
Current Debt
0.139.150.10012.390.16
Other Current Liabilities
2.954.200000.04
Total Current Liabilities
15.2730.063.335.463.5914.860.21
Long-Term Debt
0.471.10.070000
Other Long-Term Liabilities
5.760.10--73.76-
Total Long-Term Liabilities
6.231.20.070073.760
Total Liabilities
21.531.263.45.463.5988.620.21
Total Debt
0.6110.260.170012.390.16
Debt Growth
-94.10%5933.19%---7641.65%-
Common Stock
279.0920.16178.77177.6312600.05
Retained Earnings
-142.69-32.6-142.24-118.96-108.56-86.22-0.24
Shareholders' Equity
136.41-12.4336.5458.6717.44-86.22-0.19
Total Liabilities and Equity
157.9118.8339.9464.1221.032.40.02
Net Cash / Debt
148.38-5.838.3962.6520.29-10.71-0.14
Net Cash / Debt Growth
---38.72%208.87%---
Net Cash Per Share
16.63-2.2814.1927.7014.04-188.34-0.42
Working Capital
136-11.3736.2458.5317.31-12.63-0.19
Book Value Per Share
15.29-4.8913.5025.9312.07-1.00-0.56
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).